Evaluating the metabolic alterations in pancreatic cancer

Aneesha Dasgupta, Surendra K. Shukla, Venugopal Gunda, Ryan J. King, Pankaj K. Singh

Research output: Chapter in Book/Report/Conference proceedingChapter

Abstract

Metabolic reprograming is an established hallmark of cancer cells. Pancreatic cancer cells, by virtue of the underlying oncogenic drivers, demonstrate metabolic reprograming to sustain growth, invasiveness, and therapy resistance. The increased demands of the growing tumor cells alter the metabolic and signaling pathways to meet the growing nutrient requirements. Investigating the metabolic vulnerabilities of tumor cells can help in developing effective therapeutics to target pancreatic cancer. In this chapter, we explain in detail the methods to evaluate the metabolic changes occurring in the tumor. This includes the glucose/glutamine uptake assays and the measurement of reactive oxygen species, extracellular acidification rate, and oxygen consumption rate in the tumor cells. All these physiological assays help in understanding the metabolic nature of the tumor.

Original languageEnglish (US)
Title of host publicationMethods in Molecular Biology
PublisherHumana Press Inc.
Pages221-228
Number of pages8
DOIs
StatePublished - 2019

Publication series

NameMethods in Molecular Biology
Volume1882
ISSN (Print)1064-3745

Keywords

  • Cancer metabolism
  • ECAR
  • Glucose uptake
  • Glutamine uptake
  • OCR
  • Pancreatic cancer
  • Reactive oxygen species

ASJC Scopus subject areas

  • Molecular Biology
  • Genetics

Fingerprint Dive into the research topics of 'Evaluating the metabolic alterations in pancreatic cancer'. Together they form a unique fingerprint.

  • Cite this

    Dasgupta, A., Shukla, S. K., Gunda, V., King, R. J., & Singh, P. K. (2019). Evaluating the metabolic alterations in pancreatic cancer. In Methods in Molecular Biology (pp. 221-228). (Methods in Molecular Biology; Vol. 1882). Humana Press Inc.. https://doi.org/10.1007/978-1-4939-8879-2_20